Legal & General Group PLC Orchard Therapeutics PLC Transaction History

Legal & General Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$0.42 - $0.78 $34,197 - $63,509	-81,422 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.23 $27,326 - $52,532	23,557 Added 40.71%	81,422 $108,000
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $16,475 - $31,552	7,355 Added 14.56%	57,865 $133,000
Q2 2021 Aug 12, 2021	SELL	$4.39 - $7.23 $58,654 - $96,600	-13,361 Reduced 20.92%	50,510 $221,000
Q1 2021 May 17, 2021	BUY	$4.39 - $9.08 $29,421 - $60,854	6,702 Added 11.72%	63,871 $463,000
Q4 2020 Feb 12, 2021	BUY	$3.86 - $5.07 $121,837 - $160,029	31,564 Added 123.27%	57,169 $246,000
Q2 2020 Aug 14, 2020	BUY	$5.75 - $11.99 $80,316 - $167,476	13,968 Added 120.03%	25,605 $154,000
Q1 2020 May 14, 2020	BUY	$5.65 - $15.71 $19,323 - $53,728	3,420 Added 41.62%	11,637 $87,000
Q4 2019 Feb 13, 2020	BUY	$10.15 - $15.58 $63,386 - $97,297	6,245 Added 316.68%	8,217 $113,000
Q3 2019 Nov 13, 2019	BUY	$11.88 - $16.72 $3,564 - $5,016	300 Added 17.94%	1,972 $23,000
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.63 $22,070 - $34,493	1,672 New	1,672 $23,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.